NEIL2

nei like DNA glycosylase 2, the group of DNA glycosylases

Basic information

Region (hg38): 8:11769639-11787345

Links

ENSG00000154328NCBI:252969OMIM:608933HGNC:18956Uniprot:Q969S2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NEIL2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEIL2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
3
clinvar
5
missense
32
clinvar
2
clinvar
2
clinvar
36
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 33 4 6

Variants in NEIL2

This is a list of pathogenic ClinVar variants found in the NEIL2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-11771457-G-A not specified Uncertain significance (Apr 01, 2024)3299187
8-11771462-G-A Likely benign (Apr 01, 2022)2658412
8-11771482-A-G not specified Likely benign (Jun 11, 2024)3299185
8-11771508-C-G not specified Uncertain significance (Feb 06, 2023)2455687
8-11771524-G-C High myopia Uncertain significance (Dec 17, 2018)623436
8-11771550-G-A not specified Uncertain significance (Jun 29, 2022)3191375
8-11771561-G-A Benign (Apr 05, 2018)771875
8-11771576-G-C not specified Uncertain significance (Apr 10, 2023)2570313
8-11771581-C-G not specified Uncertain significance (Jun 24, 2022)2297539
8-11779658-A-G not specified Uncertain significance (May 28, 2024)3299188
8-11779664-C-G Likely benign (Apr 05, 2018)786554
8-11779680-C-T not specified Likely benign (May 08, 2023)2563056
8-11779766-C-T Benign (Jun 06, 2018)785243
8-11779785-C-T not specified Uncertain significance (Dec 27, 2023)3191386
8-11779796-G-T not specified Uncertain significance (Jan 30, 2024)3191395
8-11779827-C-T not specified Uncertain significance (Jan 09, 2024)3191399
8-11779843-GA-G Uncertain significance (Jan 14, 2016)285692
8-11779849-G-T not specified Uncertain significance (Dec 09, 2023)3191402
8-11779856-G-C not specified Uncertain significance (Oct 10, 2023)3191404
8-11779879-C-T Likely benign (Mar 30, 2018)726161
8-11779911-A-C not specified Uncertain significance (Jun 24, 2022)2217449
8-11779911-A-T not specified Uncertain significance (Aug 04, 2023)2598573
8-11779914-C-T not specified Uncertain significance (Mar 01, 2024)3191408
8-11779921-G-T not specified Uncertain significance (Dec 19, 2023)3191411
8-11779934-A-G not specified Uncertain significance (Jan 05, 2022)2206701

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NEIL2protein_codingprotein_codingENST00000284503 417708
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.87e-110.022412564101071257480.000426
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-2.092641841.430.00001002155
Missense in Polyphen8862.0011.4193828
Synonymous-2.8411279.71.400.00000488653
Loss of Function-0.5301512.91.166.23e-7147

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008210.000821
Ashkenazi Jewish0.000.00
East Asian0.0002720.000272
Finnish0.0001390.000139
European (Non-Finnish)0.0003100.000308
Middle Eastern0.0002720.000272
South Asian0.001110.00111
Other0.0008170.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in base excision repair of DNA damaged by oxidation or by mutagenic agents. Has DNA glycosylase activity towards 5-hydroxyuracil and other oxidized derivatives of cytosine with a preference for mismatched double-stranded DNA (DNA bubbles). Has low or no DNA glycosylase activity towards thymine glycol, 2-hydroxyadenine, hypoxanthine and 8-oxoguanine. Has AP (apurinic/apyrimidinic) lyase activity and introduces nicks in the DNA strand. Cleaves the DNA backbone by beta-delta elimination to generate a single-strand break at the site of the removed base with both 3'- and 5'-phosphates. {ECO:0000269|PubMed:12097317, ECO:0000269|PubMed:14522990, ECO:0000269|PubMed:15175427, ECO:0000269|PubMed:15339932}.;
Pathway
Base excision repair - Homo sapiens (human);DNA Repair;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Base Excision Repair;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway (Consensus)

Recessive Scores

pRec
0.0775

Intolerance Scores

loftool
0.948
rvis_EVS
0.13
rvis_percentile_EVS
63.57

Haploinsufficiency Scores

pHI
0.0532
hipred
Y
hipred_score
0.518
ghis
0.463

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.794

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Neil2
Phenotype
cellular phenotype; normal phenotype; hematopoietic system phenotype; respiratory system phenotype; immune system phenotype;

Gene ontology

Biological process
base-excision repair;nucleotide-excision repair;depyrimidination
Cellular component
nucleus;nucleoplasm;cytoplasm;spindle microtubule;intracellular membrane-bounded organelle
Molecular function
damaged DNA binding;DNA-(apurinic or apyrimidinic site) endonuclease activity;protein binding;microtubule binding;zinc ion binding;DNA N-glycosylase activity;class I DNA-(apurinic or apyrimidinic site) endonuclease activity